| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07321951 A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-05 | NCT07232576 A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-14 | NCT07354932 A Study of SHR-2173 in Participants With Primary IgA Nephropathy |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07640451 A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in… | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07622342 A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07309055 | A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis | Adolescents With Moderate-to-severe Atopic Dermatitis | Recruiting |
| Phase 2/3 | |||
| NCT06554509 | Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With… | Prurigo Nodularis | Recruiting |
| Phase 2 | |||
| NCT07289763 | Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety… | Primary Membranous Nephropathy | Recruiting |
| NCT07211542 | A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With… | Moderate-to-severe Atopic Dermatitis | Recruiting |
| NCT07299422 | A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Recruiting |
| NCT07354932 | A Study of SHR-2173 in Participants With Primary IgA Nephropathy | Primary IgA Nephropathy | Recruiting |
| NCT07444684 | A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum | Pyoderma Gangrenosum | Not Yet Recruiting |
| NCT07233655 | A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis | Moderate to Severe Active Rheumatoid Arthritis | Active, Not Recruiting |
| NCT07622342 | A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis | Generalized Myasthenia Gravis | Not Yet Recruiting |
| NCT07232576 | A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in… | Adult Patients With Moderately to Severely Active Ulcerative Colitis | Active, Not Recruiting |
| NCT07321951 | A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis | Moderate-to-severe Atopic Dermatitis | Active, Not Recruiting |
| NCT07640451 | A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in… | COPD | Not Yet Recruiting |
| Phase 1 | |||
| NCT07116915 | A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a… | COPD | Recruiting |
| NCT07229716 | Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects | Pulmonary Fibrosis | Recruiting |
| NCT07206758 | Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia | Immune Thrombocytopenia | Recruiting |
| NCT06993116 | A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Active, Not Recruiting |
| NCT07264335 | A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using… | Atopic Dermatitis | Active, Not Recruiting |
| NCT07567872 | A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics… | COPD | Not Yet Recruiting |